Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

(2021) René Westhovens et al.   ANNALS OF THE RHEUMATIC DISEASES

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

(2021) Bernard Combe et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs

(2021) Arthur Kavanaugh et al.   JOURNAL OF RHEUMATOLOGY

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib

(2021) Paqui G Traves et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

(2020) Philip Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

(2020) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy

(2019) Mark C. Genovese et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

(2018) Kevin L Winthrop et al.   INFLAMMATORY BOWEL DISEASES

Causes of death in rheumatoid arthritis: How do they compare to the general population?

(2018) Jessica Widdifield et al.   ARTHRITIS CARE & RESEARCH

Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment

(2018) Josef S. Smolen et al.   JOURNAL OF RHEUMATOLOGY

Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)

(2016) A Kavanaugh et al.   ANNALS OF THE RHEUMATIC DISEASES

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)

(2016) R Westhovens et al.   ANNALS OF THE RHEUMATIC DISEASES

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

(2016) J. van den Hoek et al.   RHEUMATOLOGY INTERNATIONAL

Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses’ Health Study

(2016) Jeffrey A. Sparks et al.   ARTHRITIS CARE & RESEARCH

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries

(2015) Johan Askling et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

(2015) Jasvinder A Singh et al.   LANCET

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

(2015) Vibeke Strand et al.   ARTHRITIS RESEARCH & THERAPY

Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study

(2014) Alexis Ogdie et al.   ANNALS OF THE RHEUMATIC DISEASES

Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

(2014) Stanley Cohen et al.   Arthritis & Rheumatology

The risk of venous thromboembolism in patients with rheumatoid arthritis

(2013) Seoyoung C. Kim et al.   ARTHRITIS CARE & RESEARCH

Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization

(2012) Marie E. Holmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis

(2012) Sabrina Dadoun et al.   JOINT BONE SPINE

Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

(2012) Jessica Widdifield et al.   ARTHRITIS CARE & RESEARCH

Confidence Intervals for Difference Between Two Poisson Rates

(2011) Hui-Qiong Li et al.   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM